Cargando…
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
BACKGROUND: Transcutaneous supraorbital nerve stimulation (tSNS) with the Cefaly® device was recently found superior to sham stimulation for episodic migraine prevention in a randomized trial. Its safety and efficiency in larger cohorts of headache sufferers in the general population remain to be de...
Autores principales: | Magis, Delphine, Sava, Simona, d’Elia, Tullia Sasso, Baschi, Roberta, Schoenen, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177534/ https://www.ncbi.nlm.nih.gov/pubmed/24289825 http://dx.doi.org/10.1186/1129-2377-14-95 |
Ejemplares similares
-
Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly® device (PREMICE): a multi-centre, randomized, sham-controlled trial
por: Schoenen, J, et al.
Publicado: (2013) -
Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly(®) Device for Migraine Prevention: A Review of the Available Data
por: Riederer, Franz, et al.
Publicado: (2015) -
Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects
por: Piquet, Maxime, et al.
Publicado: (2011) -
Transcutaneous Vagus Nerve Stimulation (tVNS) for headache prophylaxis: initial experience
por: Magis, D, et al.
Publicado: (2013) -
Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience
por: Russo, Antonio, et al.
Publicado: (2015)